SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 79.49 |
| Enterprise Value ($M) | 51.83 |
| Book Value ($M) | 193.03 |
| Book Value / Share | 2.16 |
| Price / Book | 0.41 |
| NCAV ($M) | 169.37 |
| NCAV / Share | 1.90 |
| Price / NCAV | 0.47 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -0.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.25 |
| Current Ratio | 10.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 189.11 |
| Assets | 212.77 |
| Liabilities | 19.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.32 |
| Operating Income | -93.06 |
| Net Income | -82.09 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -69.09 |
| Cash from Investing | 70.60 |
| Cash from Financing | 0.31 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ra Capital Management, L.p. | 9.90 | 35.35 | |
| 13G/A | Rubric Capital Management LP | 0.00 | -100.00 | |
| 13G/A | BlackRock Inc. | 1.30 | -77.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 54,959 | 223,923 | 24.54 | |
| 48,210 | 238,789 | 20.19 | |
| 24,112 | 10,958 | 220.04 | |
| 38,783 | 21,676 | 178.92 | |
| 40,952 | 36,457 | 112.33 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CGTX – Cognition Therapeutics, Inc. | CHRS – Coherus BioSciences, Inc. |
| CLSD – Clearside Biomedical, Inc. | CRMD – CorMedix Inc. |
| CRON – Cronos Group Inc. |
Financial data and stock pages provided by
Fintel.io